PT88404A - Dosage form comprising fast agent delivery followed by slow agent delivery - Google Patents

Dosage form comprising fast agent delivery followed by slow agent delivery

Info

Publication number
PT88404A
PT88404A PT88404A PT8840488A PT88404A PT 88404 A PT88404 A PT 88404A PT 88404 A PT88404 A PT 88404A PT 8840488 A PT8840488 A PT 8840488A PT 88404 A PT88404 A PT 88404A
Authority
PT
Portugal
Prior art keywords
agent delivery
dosage form
slow
followed
fast
Prior art date
Application number
PT88404A
Other languages
English (en)
Other versions
PT88404B (pt
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of PT88404A publication Critical patent/PT88404A/pt
Publication of PT88404B publication Critical patent/PT88404B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
PT88404A 1987-09-03 1988-09-02 Forma de dosagem que compreende a libertacao de agente rapido seguida pela libertacao de agente lento PT88404B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/092,857 US4814181A (en) 1987-09-03 1987-09-03 Dosage form comprising fast agent delivery followed by slow agent delivery

Publications (2)

Publication Number Publication Date
PT88404A true PT88404A (pt) 1989-07-31
PT88404B PT88404B (pt) 1993-02-26

Family

ID=22235509

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88404A PT88404B (pt) 1987-09-03 1988-09-02 Forma de dosagem que compreende a libertacao de agente rapido seguida pela libertacao de agente lento

Country Status (23)

Country Link
US (1) US4814181A (pt)
JP (1) JPH0196116A (pt)
KR (1) KR950006216B1 (pt)
AR (1) AR241676A1 (pt)
AT (1) AT400296B (pt)
AU (1) AU612397B2 (pt)
BE (1) BE1001184A3 (pt)
CA (1) CA1288016C (pt)
CH (1) CH676794A5 (pt)
DE (1) DE3829942A1 (pt)
DK (1) DK485588A (pt)
ES (1) ES2008580A6 (pt)
FI (1) FI884056A (pt)
FR (1) FR2620025B1 (pt)
GB (1) GB2209280B (pt)
IE (1) IE61845B1 (pt)
IT (1) IT1223798B (pt)
LU (1) LU87326A1 (pt)
NL (1) NL8802180A (pt)
NO (1) NO176902C (pt)
PT (1) PT88404B (pt)
SE (1) SE8803084L (pt)
ZA (1) ZA886435B (pt)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US4915952A (en) * 1987-02-27 1990-04-10 Alza Corporation Composition comprising drug, HPC, HPMC and PEO
US4915953A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering acetaminophen or phenylpropanolamine
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US5126142A (en) * 1989-07-18 1992-06-30 Alza Corporation Dispenser comprising ionophore
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5045082A (en) * 1990-01-10 1991-09-03 Alza Corporation Long-term delivery device including loading dose
US5151093A (en) * 1990-10-29 1992-09-29 Alza Corporation Osmotically driven syringe with programmable agent delivery
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
US5801141A (en) * 1991-06-24 1998-09-01 American Cyanamid Company Implant compositions containing a biologically active protein, peptide or polypeptide
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5240713A (en) * 1991-09-27 1993-08-31 Alza Corporation Dual rate agent delivery device
US5200194A (en) * 1991-12-18 1993-04-06 Alza Corporation Oral osmotic device
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
NZ245514A (en) * 1991-12-27 1994-12-22 Merck & Co Inc Controlled release drug delivery device comprising a core and a polymeric coating which is water impermeable but contains apertures to expose the core
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
DK0957899T3 (da) * 1996-08-16 2003-04-22 Alza Corp Doseringsform til tilvejebringelse af stigende dosis lægemiddel
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US6669954B2 (en) 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
BR0115585A (pt) 2000-11-28 2005-12-13 Fmc Corp Composições de revestimento de pronta liberação, endurecìvel, comestìvel, seca e, úmida, forma de dosagem sólida, e, método para revestir uma forma de dosagem sólida farmacêutica ou veterinária, confeito, semente, ração animal, fertilizante, comprimido de pesticida ou alimento
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
US8329217B2 (en) * 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
UY28056A1 (es) * 2002-10-31 2003-12-31 Alza Corp Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida.
US20040089308A1 (en) * 2002-11-13 2004-05-13 Welch Robert A. Cervical ring to deliver medication
WO2004060355A1 (en) * 2002-12-26 2004-07-22 Pozen Inc. Multilayer Dosage Forms Containing NSAIDs and Triptans
AU2004275826A1 (en) * 2003-09-26 2005-04-07 Alza Corporation OROS push-stick for controlled delivery of active agents
US7897172B2 (en) * 2004-05-18 2011-03-01 L. Perrigo Company Tablets exhibiting reduced drug release variability
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
ES2528403T3 (es) 2005-04-28 2015-02-09 Proteus Digital Health, Inc. Sistemas informáticos farmacéuticos
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US20070190137A1 (en) * 2005-10-07 2007-08-16 Reyes Iran Osmotic dosage form with controlled release and fast release aspects
CN101360484B (zh) * 2005-11-18 2012-01-25 葛兰素集团有限公司 用于药物和类似药物的产品组装的设备和方法
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
US20080207593A1 (en) * 2007-02-28 2008-08-28 Collegium Pharmaceutical, Inc. Antihistamine Combination
US8404275B2 (en) * 2007-07-01 2013-03-26 Vitalis Llc Combination tablet with chewable outer layer
US20090246276A1 (en) 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
BRPI1015298A2 (pt) 2009-04-28 2018-05-22 Proteus Biomedical Inc marcadores de evento de ingerível altamente confiável e métodos para usar os mesmos
UA109424C2 (uk) * 2009-12-02 2015-08-25 Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки
BR112012025650A2 (pt) 2010-04-07 2020-08-18 Proteus Digital Health, Inc. dispositivo ingerível miniatura
EP2642983A4 (en) 2010-11-22 2014-03-12 Proteus Digital Health Inc DEVICE INGREABLE WITH PHARMACEUTICAL PRODUCT
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
CN107296798A (zh) 2011-10-28 2017-10-27 维塔利斯公司 抗发红组合物
WO2014120669A1 (en) 2013-01-29 2014-08-07 Proteus Digital Health, Inc. Highly-swellable polymeric films and compositions comprising the same
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
CA2936740C (en) 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
AU2017300786B2 (en) 2016-07-22 2020-03-05 Otsuka Pharmaceutical Co., Ltd. Electromagnetic sensing and detection of ingestible event markers
US10820831B2 (en) 2016-10-26 2020-11-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers
US9707217B1 (en) 2017-02-03 2017-07-18 Osmotica Kereskedelmi Es Szolgaltato Kft Dose-dumping resistant controlled release dosage form
KR20180071226A (ko) 2018-06-12 2018-06-27 김성규 관성을 이용한 자동차 연료 절약 장치
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175029C (nl) * 1970-12-23 1984-09-17 Boehringer Sohn Ingelheim Depotdragee, die bekleed is met een onoplosbare en onverteerbare schaal, die op een of meer plaatsen een uitsparing vertoont.
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4475916A (en) * 1982-03-18 1984-10-09 Merck & Co., Inc. Osmotic drug delivery system
DK90883A (da) * 1982-03-18 1983-09-19 Merck & Co Inc Beholder til osmotisk afgivelse af et stof eller en stofblanding
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications
US4673405A (en) * 1983-03-04 1987-06-16 Alza Corporation Osmotic system with instant drug availability
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4608048A (en) * 1984-12-06 1986-08-26 Alza Corporation Dispensing device with drug delivery patterns
US4643731A (en) * 1985-08-16 1987-02-17 Alza Corporation Means for providing instant agent from agent dispensing system
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
GB2189702B (en) * 1986-04-30 1989-10-18 Alza Corp Dosage form with improved delivery capability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine

Also Published As

Publication number Publication date
GB8820460D0 (en) 1988-09-28
IT1223798B (it) 1990-09-29
SE8803084D0 (sv) 1988-09-02
AU612397B2 (en) 1991-07-11
LU87326A1 (fr) 1989-03-08
KR890004684A (ko) 1989-05-09
FI884056A0 (fi) 1988-09-02
CA1288016C (en) 1991-08-27
AR241676A1 (es) 1992-10-30
IE61845B1 (en) 1994-11-30
NO176902C (no) 1995-06-21
FR2620025B1 (fr) 1990-04-20
JPH0196116A (ja) 1989-04-14
ATA214488A (de) 1995-04-15
KR950006216B1 (ko) 1995-06-12
FI884056A (fi) 1989-03-04
US4814181A (en) 1989-03-21
SE8803084L (sv) 1989-03-04
BE1001184A3 (fr) 1989-08-08
NO883837D0 (no) 1988-08-29
NO176902B (no) 1995-03-13
ZA886435B (en) 1989-05-30
IT8867790A0 (it) 1988-09-02
PT88404B (pt) 1993-02-26
AT400296B (de) 1995-11-27
DK485588D0 (da) 1988-09-01
GB2209280A (en) 1989-05-10
NO883837L (no) 1989-03-06
GB2209280B (en) 1991-09-04
FR2620025A1 (fr) 1989-03-10
DK485588A (da) 1989-03-04
ES2008580A6 (es) 1989-07-16
DE3829942A1 (de) 1989-03-16
IE882641L (en) 1989-03-03
NL8802180A (nl) 1989-04-03
CH676794A5 (pt) 1991-03-15
AU2152688A (en) 1989-03-09

Similar Documents

Publication Publication Date Title
PT88404A (pt) Dosage form comprising fast agent delivery followed by slow agent delivery
DE3774264D1 (de) Pseudoephedrin-dosierungsform.
IT1219402B (it) Dispensatore di farmaci
SE8801813D0 (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
NO883962L (no) Doseringsapparat.
DK89090A (da) Farmaceutisk praeparat
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
IS3339A7 (is) Ný efnablanda lyfja
NO882653D0 (no) Doseringsform.
IT1219401B (it) Dispensatore di farmaci
DE3382112D1 (de) Pharmazeutische zusammensetzung.
DE68907177D1 (de) Dosierungsform.
FI883673A (fi) Farmaceutiska kompositioner.
KR900011466A (ko) 고상 투여형용 안정화계
ATA133288A (de) Pharmazeutische zusammensetzung
DE68907609D1 (de) Arzneimittelzusammensetzung.
BR8806448A (pt) Dosador medicinal
KR880014683U (ko) 배달물 투입기
SE8705100D0 (sv) Farmaceutisk komposition
SE8700576D0 (sv) Pharmaceutical composition
RO86248A2 (ro) Medicament antiasmatic
ATE90556T1 (de) Dosierungsform.
IT8722591A0 (it) Formulazione farmaceutica contenente gemfibrozilmicroincapsulato.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920820

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19970228